Upload Image (Max 20MB per Image)
Santaris Pharma and miRagen Therapeutics have extended their research deal to discover and develop LNA-drugs against disease causing microRNAs. The agreement allows miRagen to gain a non-exclusive license to the miRNA therapeutics field ...
Tags: Santaris Pharma, miRagen Therapeutics, microRNAs